Effect of passive smoking on theophylline clearance in children.
The author investigated the effects of passive tobacco smoking on the metabolism of theophylline in a pediatric population. In a retrospective analysis of 201 children admitted to a pediatric unit for asthma, 31 were identified with an acute exacerbation of asthma of noninfectious origin in which environmental exposure to tobacco smoke could be established. The parents were known smokers with a minimum 1-pack-per-day habit. An age-and gender-matched control population of children was then identified who had an acute exacerbation of asthma without any environmental exposure to tobacco smoke. In addition, the patients in both groups received the same dose of intravenous aminophylline for a minimum of 48 hours to ensure steady-state conditions. Total body clearance of theophylline was significantly elevated in the children exposed to environmental tobacco smoke (1.36 +/- 0.09 vs. 0.90 +/- 0.04 mL/min per kg, p < 0.0001). Steady-state serum levels were significantly lower in the passive smoking group (55.3 +/- 2.8 vs. 73.2 +/- 3.3 p < 0.00001) for those receiving nearly identical intravenous doses. The length of hospital stay was longer in the group exposed to passive smoke (4.4 +/- 2.6 vs. 2.9 +/- 1.3 days, p < 0.05). The clearance of theophylline is greater in asthmatic children exposed to passive tobacco smoke than in asthmatic children not exposed to passive tobacco smoke. These findings suggest that passive smoking may increase the clearance of other drugs metabolized in a manner similar to theophylline.
Mayo
P R
PR
University of Alberta Hospital, Edmonton, Alberta, Canada. pmayo@cha.ab.ca
D001249:Asthma / Q000453:epidemiology / Q000209:etiology*; D001993:Bronchodilator Agents / Q000097:blood / Q000493:pharmacokinetics*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D012189:Retrospective Studies; D013806:Theophylline / Q000097:blood / Q000493:pharmacokinetics*; D014028:Tobacco Smoke Pollution / Q000009:adverse effects*
D001993:Bronchodilator Agents; D014028:Tobacco Smoke Pollution; D013806:Theophylline